1. AstraZeneca plans 2020 filing for lupus drug — Shares of Amarin rise on positive FDA committee report on Vascepa — Amgen cutting 149 neuroscience R&D staff — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Edit Tags: What Company?

Multiple tags may be separated by commas.